HERTFORDSHIRE, England and
PITTSBURGH, May 4, 2016 /PRNewswire/ -- Mylan N.V. (NASDAQ,
TASE: MYL) today announced that the Company will present at the
Bank of America Merrill Lynch 19th Annual Health Care
Conference on Tuesday, May 10, 2016,
in Las Vegas, NV. The presentation
is scheduled to begin at 3:40 p.m.
PDT / 6:40 p.m. EDT.
Interested parties can access a live webcast of the presentation
via the investor relations section of Mylan's Web site at
www.mylan.com/investors.
About Mylan
Mylan is a global pharmaceutical company committed to setting
new standards in healthcare. Working together around the world to
provide 7 billion people access to high quality medicine, we
innovate to satisfy unmet needs; make reliability and service
excellence a habit; do what's right, not what's easy; and impact
the future through passionate global leadership. We offer a growing
portfolio of more than 1,400 generic and branded pharmaceuticals,
including antiretroviral therapies on which approximately 50% of
people being treated for HIV/AIDS in the developing world depend.
We market our products in approximately 165 countries and
territories. Our global R&D and manufacturing platform includes
more than 50 facilities, and we are one of the world's largest
producers of active pharmaceutical ingredients. Every member of our
nearly 35,000-strong workforce is dedicated to creating better
health for a better world, one person at a time. Learn more at
mylan.com.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/mylan-to-present-at-the-bank-of-america-merrill-lynch-19th-annual-health-care-conference-300262557.html
SOURCE Mylan N.V.